Back to Companies
OCULAR THERAPEUTIX, INC
OCULNasdaqCIK: 0001393434
Recent Form 4 activity at OCULAR THERAPEUTIX, INC (OCUL) spans 42 filings across 16 insiders (1 buying and 7 selling). Purchases total $461.4K against $2.8M in sales — heavily weighted toward selling, for net sales of $2.4M. Robinson David Wayne (Global CCO) is the most active by dollar volume, and the single largest transaction was $4.8M by Robinson David Wayne. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$18.1M
Purchases
$461.4K
Sales
$2.8M
Unique Insiders
16
Recent Insider Trades
42 loaded
| Jun 18 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Gift | $0 |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | Robins Jason Shand | Chief Financial Officer | Grant | $122.6K |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | Williams Leslie J. | Director | Grant | $384.6K |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Director | Grant | $384.6K |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | RAINES MERILEE | Director | Grant | $384.6K |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | Warden Charles M | Director | Grant | $384.6K |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | Hong Seung Suh | Director | Grant | $384.6K |
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | Graves Adrienne L | Director | Grant | $384.6K |
| Jun 5 | OCUL OCULAR THERAPEUTIX, INC | Waheed Nadia | Chief Medical Officer | Sell | $122.6K |
| May 28 | OCUL OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Officer | Sell | $15.2K |
| May 28 | OCUL OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Officer | Sell | $24.3K |
| May 28 | OCUL OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Chief Scientific Officer | Sell | $24.7K |
| May 28 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Sell | $173.5K |
| Apr 13 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Gift | $0 |
| Feb 25 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Sell | $166.1K |
| Feb 25 | OCUL OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Chief Scientific Officer | Sell | $25.3K |
| Feb 25 | OCUL OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Officer | Sell | $14.6K |
| Feb 25 | OCUL OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Officer | Sell | $23.3K |
| Feb 24 | OCUL OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Director | Buy | $461.4K |
| Feb 24 | OCUL OCULAR THERAPEUTIX, INC | Waheed Nadia | Chief Medical Officer | Sell | $27.2K |
| Feb 17 | OCUL OCULAR THERAPEUTIX, INC | Waheed Nadia | Chief Medical Officer | Sell | $71.1K |
| Feb 17 | OCUL OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Officer | Sell | $93.5K |
| Feb 17 | OCUL OCULAR THERAPEUTIX, INC | Notman Donald | Chief Operating Officer | Sell | $103.5K |
| Feb 17 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Sell | $1.1M |
| Feb 4 | OCUL OCULAR THERAPEUTIX, INC | Notman Donald | Chief Operating Officer | Sell | $101.4K |
| Jan 26 | OCUL OCULAR THERAPEUTIX, INC | Robinson David Wayne | Global CCO | Other | $0 |
| Jan 26 | OCUL OCULAR THERAPEUTIX, INC | Robinson David Wayne | Global CCO | Grant | $4.8M |
| Jan 22 | OCUL OCULAR THERAPEUTIX, INC | Robins Jason Shand | Interim CFO | Award | $377.9K |
| Jan 22 | OCUL OCULAR THERAPEUTIX, INC | Robins Jason Shand | Interim CFO | Other | $0 |
| Jan 6 | OCUL OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Officer | Grant | $2.8M |
| Jan 6 | OCUL OCULAR THERAPEUTIX, INC | Saroj Namrata | Chief Business Officer | Grant | $2.8M |
| Oct 10 | OCUL OCULAR THERAPEUTIX, INC | Anderman Todd | Chief Legal Officer | Sell | $137.4K |
| Oct 6 | OCUL OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Officer | Sell | $106.5K |
| Oct 6 | OCUL OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Chief Scientific Officer | Sell | $115.9K |
| Sep 11 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Gift | $0 |
| Sep 4 | OCUL OCULAR THERAPEUTIX, INC | Notman Donald | See Remarks | Sell | $13.3K |
| Aug 27 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Sell | $258.8K |
| Aug 27 | OCUL OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Officer | Sell | $36.3K |
| Aug 27 | OCUL OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Chief Scientific Officer | Sell | $36.9K |
| Aug 27 | OCUL OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Officer | Sell | $22.7K |
| Aug 14 | OCUL OCULAR THERAPEUTIX, INC | Waheed Nadia | Chief Medical Officer | Grant | $1.5M |
| Aug 13 | OCUL OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Director | Gift | $0 |
42 filings